- Home
- NKTR vs PHK Comparison
NKTR vs PHK Comparison
Compare NKTR & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$36.10
Company Overview
Basic Information| Metric | NKTR | PHK |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 807.8M | 842.0M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | NKTR | PHK |
|---|---|---|
| Price | $36.10 | $4.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $111.83 | N/A |
| AVG Volume (30 Days) | ★ 688.3K | 491.5K |
| Earning Date | 03-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,600,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.48 | $4.13 |
| 52 Week High | $66.92 | $5.15 |
Technical Indicators
Market Signals| Indicator | NKTR | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 34.41 | 63.69 |
| Support Level | $35.03 | $4.86 |
| Resistance Level | $38.29 | $4.92 |
| Average True Range (ATR) | 2.30 | 0.03 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 18.73 | 60.71 |
Price Performance
Historical Comparison NKTR
PHK
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.